Perspective Therapeutics (CATX) Non Operating Income (2010 - 2026)

Perspective Therapeutics (CATX) has 17 years of Non Operating Income data on file, last reported at $2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 42.76% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (down 7.4% YoY), and the FY2025 full-year result was $9.1 million, down 12.65% from the prior year.
• Non Operating Income fell to $2.1 million in Q1 2026, from $3.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.7 million in Q1 2025 to a low of $29000.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $458500.0 in 2022 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income slumped 94.12% in 2023 and surged 8136.36% in 2024, its largest moves.
• Tracing CATX's Non Operating Income over 5 years: stood at $561000.0 in 2022, then tumbled by 94.12% to $33000.0 in 2023, then surged by 8136.36% to $2.7 million in 2024, then jumped by 34.47% to $3.7 million in 2025, then slumped by 42.76% to $2.1 million in 2026.
• Business Quant data shows CATX's Non Operating Income at $2.1 million in Q1 2026, $3.7 million in Q1 2025, and $2.7 million in Q4 2024.